Literature DB >> 3930837

Hyperphenylalaninaemia caused by defects in biopterin metabolism.

S Kaufman.   

Abstract

The hepatic phenylalanine hydroxylating system consists of three essential components, phenylalanine hydroxylase, dihydropteridine reductase and the non-protein coenzyme, tetrahydrobiopterin. The reductase and the pterin coenzyme are also essential components of the tyrosine and tryptophan hydroxylating systems. Recent studies have shown that there are three distinct forms of phenylketonuria or hyperphenylalaninaemia, each caused by the lack of one of these essential components. The variant forms of the disease that are caused by the lack of dihydropteridine reductase or tetrahydrobiopterin are characterized by severe neurological deterioration, impaired functioning of tyrosine and tryptophan hydroxylases and the resultant deficiency of tyrosine- and tryptophan-derived monoamine neurotransmitters in brain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930837     DOI: 10.1007/bf01800655

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  46 in total

1.  THE STRUCTURE OF THE PHENYLALANINE-HYDROXYLATION COFACTOR.

Authors:  S KAUFMAN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-12       Impact factor: 11.205

2.  Atypical phenylketonuria with normal dihydropteridine reductase activity.

Authors:  F Rey; F Blandin-Savoja; J Rey
Journal:  N Engl J Med       Date:  1976-11-11       Impact factor: 91.245

3.  Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin.

Authors:  S Kaufman; G Kapatos; W B Rizzo; J D Schulman; L Tamarkin; G R Van Loon
Journal:  Ann Neurol       Date:  1983-09       Impact factor: 10.422

4.  Protein deficiency in PKU.

Authors: 
Journal:  N Engl J Med       Date:  1979-01-25       Impact factor: 91.245

5.  Letter: A new molecular defect in phenylketonuria.

Authors:  K Bartholome
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

6.  Diagnosis of dihydropteridine reductase deficiency by erythrocyte enzyme assay.

Authors:  K Narisawa; N Arai; H Hayakawa; K Tada
Journal:  Pediatrics       Date:  1981-10       Impact factor: 7.124

7.  Letter: New forms of phenylketonuria.

Authors:  S Kaufman; S Milstien; K Bartholomé
Journal:  Lancet       Date:  1975-10-11       Impact factor: 79.321

8.  Letter: L-dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine-hydroxylase activity.

Authors:  K Bartholomé; D J Byrd
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

9.  Biosynthesis of tetrahydrobiopterin by de novo and salvage pathways in adrenal medulla extracts, mammalian cell cultures, and rat brain in vivo.

Authors:  C A Nichol; C L Lee; M P Edelstein; J Y Chao; D S Duch
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

10.  Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.

Authors:  W E Seifert; J L Foxx; I J Butler
Journal:  Ann Neurol       Date:  1980-07       Impact factor: 10.422

View more
  7 in total

1.  QDPR gene mutation and clinical follow-up in Chinese patients with dihydropteridine reductase deficiency.

Authors:  De-Yun Lu; Jun Ye; Lian-Shu Han; Wen-Juan Qiu; Hui-Wen Zhang; Jian-De Zhou; Pei-Zhong Bao; Ya-Fen Zhang; Xue-Fan Gu
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

2.  Human dihydropteridine reductase: characterisation of a cDNA clone and its use in analysis of patients with dihydropteridine reductase deficiency.

Authors:  H H Dahl; W Hutchison; W McAdam; S Wake; F J Morgan; R G Cotton
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

Review 3.  Some metabolic relationships between biopterin and folate: implications for the "methyl trap hypothesis".

Authors:  S Kaufman
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

4.  Serum neopterin levels in children with hepatitis-B-related chronic liver disease and its relationship to disease severity.

Authors:  Enver Mahir Gulcan; Ipek Tirit; Ayse Anil; Erdal Adal; Gulsen Ozbay
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 5.  Pteridines and mono-amines: relevance to neurological damage.

Authors:  I Smith; D W Howells; K Hyland
Journal:  Postgrad Med J       Date:  1986-02       Impact factor: 2.401

6.  Immunocytochemical localization of GTP cyclohydrolase I in the brain, adrenal gland, and liver of mice.

Authors:  I Nagatsu; H Ichinose; M Sakai; K Titani; M Suzuki; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1995

7.  The New England Maternal PKU Project: identification of at-risk women.

Authors:  S E Waisbren; L B Doherty; I V Bailey; F J Rohr; H L Levy
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.